BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 16963140)

  • 1. Rehabilitation of adaptive immunity and regeneration of beta cells.
    Pasquali L; Fan Y; Trucco M; Ringquist S
    Trends Biotechnol; 2006 Nov; 24(11):516-22. PubMed ID: 16963140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell therapy for diabetes: stem cells, progenitors or beta-cell replication?
    Gonez LJ; Knight KR
    Mol Cell Endocrinol; 2010 Jul; 323(1):55-61. PubMed ID: 20026173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
    Tisch R; Wang B
    Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
    Boettler T; von Herrath M
    Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Islet transplantation, stem cell transfer and regenerative therapy in diabetes mellitus].
    Bretzel RG; Eckhard M; Jahr H; Brendel MD
    Dtsch Med Wochenschr; 2006 Apr; 131(16):903-6. PubMed ID: 16625486
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet replacement vs. regeneration: hope or hype?
    Ramiya V; Schatz D
    Pediatr Diabetes; 2004; 5 Suppl 2():45-56. PubMed ID: 15601374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical modeling.
    Wang X; He Z; Ghosh S
    Math Biosci; 2006 Sep; 203(1):79-99. PubMed ID: 16723139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming into pancreatic endocrine cells based on developmental cues.
    Kordowich S; Mansouri A; Collombat P
    Mol Cell Endocrinol; 2010 Jul; 323(1):62-9. PubMed ID: 20025937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond.
    Giannoukakis N; Phillips B; Trucco M
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):4-13. PubMed ID: 18540865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correction of autoimmune mechanisms underlying the development of type I diabetes mellitus by methods of cell therapy].
    Velikiĭ DA; Zakir'ianov AR; Klimenko ED; Kobozeva LP; Michunskaia AB; Pozdniakov OM
    Vestn Ross Akad Med Nauk; 2010; (9):34-42. PubMed ID: 21089446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to make pancreatic beta cells--prospects for cell therapy in diabetes.
    Nir T; Dor Y
    Curr Opin Biotechnol; 2005 Oct; 16(5):524-9. PubMed ID: 16084716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative medicine of the pancreatic beta cells.
    Yamada S; Kojima I
    J Hepatobiliary Pancreat Surg; 2005; 12(3):218-26. PubMed ID: 15995810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.